Ropeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment.
- DOI
- 10.1080/17474086.2026.2755131
- Published
- 2026 Oct 30
- Container
- Expert review of hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17474086.2026.2755131,
title = {Ropeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment.},
author = {Krecak I and Budimir J and Sabljic Sikiric A and Lucijanic M},
year = {2026},
journal = {Expert review of hematology},
doi = {10.1080/17474086.2026.2755131},
url = {https://doi.org/10.1080/17474086.2026.2755131}
}RIS
TY - JOUR TI - Ropeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment. AU - Krecak I AU - Budimir J AU - Sabljic Sikiric A AU - Lucijanic M PY - 2026 JO - Expert review of hematology DO - 10.1080/17474086.2026.2755131 UR - https://doi.org/10.1080/17474086.2026.2755131 ER -
APA
I, K., J, B., A, S. S., & M, L. (2026). Ropeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment.. Expert review of hematology. https://doi.org/10.1080/17474086.2026.2755131
Source records
- pubmed · retrieved 2026-11-11T01:56:45.095Z